Barbital
SIGMA/B0375
Synonym: 5,5-
CAS Number: 57-44-3
Empirical Formula (Hill Notation): C8H12N2O3
Molecular Weight: 184.19
EC Number: 200-331-2
MDL Number: MFCD00036212
Linear Formula: C8H12N2O3
Product Type: Chemical
| application(s) | forensics and toxicology pharmaceutical (small molecule) veterinary |
| drug control | USDEA Schedule IV; Home Office Schedule 3; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet |
| form | powder |
| InChI | 1S/C8H12N2O3/c1-3-8(4-2)5 |
| InChI key | FTOAOBMCPZCFFF-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | CCC1(CC)C(=O)NC(=O)NC1=O |
| technique(s) | gas chromatography (GC): suitable |
| HPLC: suitable |
| Application: | <ul> <li><strong>Synthesis and characterization of some pyrimidine, purine, amino acid and mixed ligand complexes: </strong> This study explores the use of Barbital in the synthesis of various ligand complexes, highlighting its application in the development of life science reagents and pharmaceutical intermediates. This could inform R and D strategies for pharmaceutical manufacturing using Barbital as a key intermediate (Masoud et al., 2008). ![]() </ul> |
| Biochem/physiol Actions: | Sedative/hypnotic |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 51361926 |


